It appears so, following a series of significant recent FDA announcements regarding Harmful and Potentially Harmful Constituent (HPHC) reporting and Premarket Tobacco Product Application (PMTA)...
Nicotine

Nov 26, 2019 | Published by Andrew Mooney
Nicotine
ENDS US 2019 is the ideal place to keep up with the ever-changing knowledge base required to operate in the nicotine products industry; the Advisory Board has worked hard to put together an exemplary agenda packed with opinion leaders across the legal, regulatory and scientific arenas and they will all give meaningful insights into what is happening in the industry and where it might go in 2020 and beyond.
Broughton is exhibiting at the event in Arlington, Virginia on 10-11th December along with other industry-leading companies supporting next generation nicotine products. Come along to discuss how we can help with ENDS regulatory challenges. It will also be an opportunity to discuss some of the recent confusing news stories and remind ourselves that vape products are 95% safer than smoking.
Ensure your business stays ahead of the competition by keeping up to date on the latest regulatory changes. Sign-up for our bi-monthly regulatory digest to have the latest information and insights served direct to your inbox.
1 minute read
It appears so, following a series of significant recent FDA announcements regarding Harmful and Potentially Harmful Constituent (HPHC) reporting and Premarket Tobacco Product Application (PMTA)...
On November 9th at the ENDS US 2022 Conference, scientific and regulatory consultancy Broughton will be presenting on the regulatory approval process for Electronic Nicotine Delivery Systems (ENDS)...
Broughton is establishing a U.S. subsidiary to enhance its presence in the region.